Adamska A, Domenichini A, Falasca M. 2017. Pancreatic ductal adenocarcinoma: current and evolving therapies. International Journal of Molecular Sciences 18:E1338:. DOI: https://doi.org/10.3390/ijms18071338, PMID: 2 8640192
Allouche-Arnon H, Wade T, Waldner LF, Miller VN, Gomori JM, Katz-Brull R, McKenzie CA. 2013. In vivo magnetic resonance imaging of glucose - initial experience. Contrast Media & Molecular Imaging 8:72–82. DOI: https://doi.org/10.1002/cmmi.1497, PMID: 23109395
Ananieva E. 2015. Targeting amino acid metabolism in Cancer growth and anti-tumor immune response. World Journal of Biological Chemistry 6:281–289. DOI: https://doi.org/10.4331/wjbc.v6.i4.281, PMID: 26629311
Anderson M, Marayati R, Moffitt R, Yeh JJ. 2017. Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic Cancer. Oncotarget 8:56081–56094. DOI: https://doi.org/10.18632/ oncotarget.9760, PMID: 28915575
Andersson CA, Bro R. 2000. The N-way toolbox for MATLAB. Chemometrics and Intelligent Laboratory Systems 52:1–4. DOI: https://doi.org/10.1016/S0169-7439(00)00071-X
Badar-Goffer RS, Bachelard HS, Morris PG. 1990. Cerebral metabolism of acetate and glucose studied by 13C-n. m.r. spectroscopy: A technique for investigating metabolic compartmentation in the brain. Biochemical Journal 266:133–139. DOI: https://doi.org/10.1042/bj2660133, PMID: 1968742
Bailey KM, Cornnell HH, Ibrahim-Hashim A, Wojtkowiak JW, Hart CP, Zhang X, Leos R, Martinez GV, Baker AF, Gillies RJ. 2014. Evaluation of the "steal" phenomenon on the efficacy of hypoxia activated prodrug TH-302 in pancreatic cancer. PLOS ONE 9:e113586. DOI: https://doi.org/10.1371/journal.pone.0113586, PMID: 25532146
Biancur DE, Paulo JA, Małachowska B, Quiles Del Rey M, Sousa CM, Wang X, Sohn ASW, Chu GC, Gygi SP, Harper JW, Fendler W, Mancias JD, Kimmelman AC. 2017. Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism. Nature Communications 8:15965. DOI: https://doi.org/10. 1038/ncomms15965, PMID: 28671190
Blum R, Kloog Y. 2014. Metabolism addiction in pancreatic Cancer. Cell Death & Disease 5:e1065. DOI: https:// doi.org/10.1038/cddis.2014.38, PMID: 24556680
Brender JR, Kishimoto S, Merkle H, Reed G, Hurd RE, Chen AP, Ardenkjaer-Larsen JH, Munasinghe J, Saito K, Seki T, Oshima N, Yamamoto K, Choyke PL, Mitchell J, Krishna MC. 2019. Dynamic imaging of glucose and lactate metabolism by 13C-MRS without hyperpolarization. Scientific Reports 9:3410. DOI: https://doi.org/10. 1038/s41598-019-38981-1
Bryant KL, Mancias JD, Kimmelman AC, Der CJ. 2014. KRAS: feeding pancreatic Cancer proliferation. Trends in Biochemical Sciences 39:91–100. DOI: https://doi.org/10.1016/j.tibs.2013.12.004, PMID: 24388967
Chen L, Weng Z, Goh L, Garland M. 2002. An efficient algorithm for automatic phase correction of NMR spectra based on entropy minimization. Journal of Magnetic Resonance 158:164–168. DOI: https://doi.org/10.1016/ S1090-7807(02)00069-1
Chiang B, Wang K, Ethier CR, Prausnitz MR. 2017. Clearance kinetics and clearance routes of molecules from the suprachoroidal space after microneedle injection. Investigative Opthalmology & Visual Science 58:545–554. DOI: https://doi.org/10.1167/iovs.16-20679
Cobas JC, Bernstein MA, Mart´ın-Pastor M, Tahoces PG. 2006. A new general-purpose fully automatic baseline- correction procedure for 1D and 2D NMR data. Journal of Magnetic Resonance 183:145–151. DOI: https://doi. org/10.1016/j.jmr.2006.07.013, PMID: 16891135
Cobas C. 2008. Why aren’t Bruker FIDs time corrected? NMR Analysis.
Crooks DR, Fan TW, Linehan WM. 2019. Metabolic labeling of cultured mammalian cells for stable Isotope- Resolved metabolomics: practical aspects of tissue culture and sample extraction. Methods in Molecular Biology 1928:1–27. DOI: https://doi.org/10.1007/978-1-4939-9027-6_1, PMID: 30725447
Cros J, Raffenne J, Couvelard A, Pote´ N. 2018. Tumor heterogeneity in pancreatic adenocarcinoma. Pathobiology 85:64–71. DOI: https://doi.org/10.1159/000477773, PMID: 28787741
Daemen A, Peterson D, Sahu N, McCord R, Du X, Liu B, Kowanetz K, Hong R, Moffat J, Gao M, Boudreau A, Mroue R, Corson L, O’Brien T, Qing J, Sampath D, Merchant M, Yauch R, Manning G, Settleman J, et al. 2015. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors. PNAS 112:E4410–E4417. DOI: https://doi.org/10.1073/pnas.1501605112, PMID: 26216 984
Daniels CJ, McLean MA, Schulte RF, Robb FJ, Gill AB, McGlashan N, Graves MJ, Schwaiger M, Lomas DJ, Brindle KM, Gallagher FA. 2016. A comparison of quantitative methods for clinical imaging with hyperpolarized (13)C-pyruvate. NMR in Biomedicine 29:387–399. DOI: https://doi.org/10.1002/nbm.3468, PMID: 27414749
De Feyter HM, Behar KL, Corbin ZA, Fulbright RK, Brown PB, McIntyre S, Nixon TW, Rothman DL, de Graaf RA. 2018. Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo. Science Advances 4:eaat7314. DOI: https://doi.org/10.1126/sciadv.aat7314, PMID: 30140744
De Lathauwer L, De Moor B, Vandewalle J. 2000. On the best rank-1 and rank-(R1,R2,R-N) Approximation of Higher-Order Tensors. SIAM Journal on Matrix Analysis and Applications 21:1324–1342. DOI: https://doi.org/ 10.1137/S0895479898346995
Deer EL, Gonza´lez-Herna´ ndez J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA, Mulvihill SJ. 2010. Phenotype and genotype of pancreatic Cancer cell lines. Pancreas 39:425–435. DOI: https://doi.org/10.1097/ MPA.0b013e3181c15963, PMID: 20418756
DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM. 1997. Involvement of endothelial PECAM-1/CD31 in angiogenesis. The American Journal of Pathology 151:671–677. PMID: 9284815
Dietrich W, Rudel CH, Neumann M. 1991. Fast and precise automatic Base-Line correction of One-Dimensional and 2-Dimensional NMR-Spectra. Journal of Magnetic Resonance 91:1–11. DOI: https://doi.org/10.1016/0022- 2364(91)90402-F
Eilers PHC. 2003. A Perfect Smoother. Analytical Chemistry 75:3631–3636. DOI: https://doi.org/10.1021/ ac034173t
Fan TWM, Lane AN. 2013. Assignment Strategies for Nuclear Magnetic Resonances in Metabolomic Research. In: Sweedler J, Lutz N. W, Wevers R. A (Eds). Methodologies for Metabolomics: Experimental Strategies and Techniques. Cambridge: Cambridge University Press. p. 525–584.
Fan TWM, Lane AN. 2016. Applications of NMR spectroscopy to systems biochemistry. Progress in Nuclear Magnetic Resonance Spectroscopy 92-93:18–53. DOI: https://doi.org/10.1016/j.pnmrs.2016.01.005, PMID: 26 952191
Faubert B, Li KY, Cai L, Hensley CT, Kim J, Zacharias LG, Yang C, Do QN, Doucette S, Burguete D, Li H, Huet G, Yuan Q, Wigal T, Butt Y, Ni M, Torrealba J, Oliver D, Lenkinski RE, Malloy CR, et al. 2017. Lactate metabolism in human lung tumors. Cell 171:358–371. DOI: https://doi.org/10.1016/j.cell.2017.09.019, PMID: 28985563
Garrido-Laguna I, Hidalgo M. 2015. Pancreatic Cancer: from state-of-the-art treatments to promising novel therapies. Nature Reviews Clinical Oncology 12:319–334. DOI: https://doi.org/10.1038/nrclinonc.2015.53, PMID: 25824606
Giordano S, Morosi L, Veglianese P, Licandro SA, Frapolli R, Zucchetti M, Cappelletti G, Falciola L, Pifferi V, Visentin S, D’Incalci M, Davoli E. 2016. 3d mass spectrometry imaging reveals a very heterogeneous drug distribution in tumors. Scientific Reports 6:37027. DOI: https://doi.org/10.1038/srep37027, PMID: 27841316
Gray LR, Tompkins SC, Taylor EB. 2014. Regulation of pyruvate metabolism and human disease. Cellular and Molecular Life Sciences 71:2577–2604. DOI: https://doi.org/10.1007/s00018-013-1539-2, PMID: 24363178 Gruetter R. 1993. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magnetic Resonance in Medicine 29:804–811. DOI: https://doi.org/10.1002/mrm.1910290613, PMID: 8350724
Guillaumond F, Leca J, Olivares O, Lavaut MN, Vidal N, Bertheze` ne P, Dusetti NJ, Loncle C, Calvo E, Turrini O, Iovanna JL, Tomasini R, Vasseur S. 2013. Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma. PNAS 110:3919–3924. DOI: https://doi.org/10.1073/ pnas.1219555110, PMID: 23407165
Gutte H, Hansen AE, Johannesen HH, Clemmensen AE, Ardenkjær-Larsen JH, Nielsen CH, Kjær A. 2015. The use of dynamic nuclear polarization C-13-pyruvate MRS in Cancer. American Journal of Nuclear Medicine and Molecular Imaging 5:548–560. PMID: 26550544
Harada M, Kubo H, Abe T, Maezawa H, Otsuka H. 2010. Selection of endogenous 13C substrates for observation of intracellular metabolism using the dynamic nuclear polarization technique. Japanese Journal of Radiology 28:173–179. DOI: https://doi.org/10.1007/s11604-009-0390-8, PMID: 20182855
Hennig J, Nauerth A, Friedburg H. 1986. RARE imaging: a fast imaging method for clinical MR. Magnetic Resonance in Medicine 3:823–833. DOI: https://doi.org/10.1002/mrm.1910030602, PMID: 3821461
Hensley CT, Faubert B, Yuan Q, Lev-Cohain N, Jin E, Kim J, Jiang L, Ko B, Skelton R, Loudat L, Wodzak M, Klimko C, McMillan E, Butt Y, Ni M, Oliver D, Torrealba J, Malloy CR, Kernstine K, Lenkinski RE, et al. 2016. Metabolic heterogeneity in human lung tumors. Cell 164:681–694. DOI: https://doi.org/10.1016/j.cell.2015.12. 034, PMID: 26853473
Hidalgo M. 2010. Pancreatic cancer. New England Journal of Medicine 362:1605–1617. DOI: https://doi.org/10. 1056/NEJMra0901557, PMID: 20427809
Hill DK, Orton MR, Mariotti E, Boult JK, Panek R, Jafar M, Parkes HG, Jamin Y, Miniotis MF, Al-Saffar NM, Beloueche-Babari M, Robinson SP, Leach MO, Chung YL, Eykyn TR. 2013. Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data. PLOS ONE 8:e71996.DOI: https://doi.org/10.1371/journal.pone.0071996, PMID: 24023724
Holm S. 1979. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 6:65–70. Hui S, Ghergurovich JM, Morscher RJ, Jang C, Teng X, Lu W, Esparza LA, Reya T, Le Zhan , Yanxiang Guo J,
White E, Rabinowitz JD. 2017. Glucose feeds the TCA cycle via circulating lactate. Nature 551:115–118. DOI: https://doi.org/10.1038/nature24057, PMID: 29045397
Jain KK. 2005. Personalised medicine for Cancer: from drug development into clinical practice. Expert Opinion on Pharmacotherapy 6:1463–1476. DOI: https://doi.org/10.1517/14656566.6.9.1463, PMID: 16086635
Jakobsen I, Kaalhus O, Lyng H, Rofstad EK. 1995. Detection of necrosis in human tumour xenografts by proton magnetic resonance imaging. British Journal of Cancer 71:456–461. DOI: https://doi.org/10.1038/bjc.1995.93, PMID: 7880724
Kamphorst JJ, Nofal M, Commisso C, Hackett SR, Lu W, Grabocka E, Vander Heiden MG, Miller G, Drebin JA, Bar-Sagi D, Thompson CB, Rabinowitz JD. 2015. Human pancreatic Cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Research 75:544–553. DOI: https://doi.org/10.1158/0008- 5472.CAN-14-2211, PMID: 25644265
Kim MP, Evans DB, Wang H, Abbruzzese JL, Fleming JB, Gallick GE. 2009. Generation of orthotopic and heterotopic human pancreatic Cancer xenografts in immunodeficient mice. Nature Protocols 4:1670–1680. DOI: https://doi.org/10.1038/nprot.2009.171, PMID: 19876027
Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM, Bastidas AJ, Vierra M. 2000. Pancreatic tumors show high levels of hypoxia. International Journal of Radiation Oncology*Biology*Physics 48:919–922. DOI: https://doi.org/10.1016/S0360-3016(00)00803-8, PMID: 11072146
Kuntner C. 2014. Kinetic modeling in pre-clinical positron emission tomography. Zeitschrift Fu¨r Medizinische Physik 24:274–285. DOI: https://doi.org/10.1016/j.zemedi.2014.02.003
Lane AN, Fan TW-M. 2007. Quantification and identification of isotopomer distributions of metabolites in crude cell extracts using 1H TOCSY. Metabolomics 3:79–86. DOI: https://doi.org/10.1007/s11306-006-0047-x
Levitt MH, Freeman R, Frenkiel T. 1982. Supercycles for Broad-Band heteronuclear decoupling. Journal of Magnetic Resonance 50:157–160. DOI: https://doi.org/10.1016/0022-2364(82)90042-7
Levitt MH, Freeman R, Frenkiel T. 1983. Broadband decoupling in High-Resolution nuclear Magnetic-Resonance spectroscopy. Advances in Magnetic and Optical Resonance 11:47–110. DOI: https://doi.org/10.1016/B978-0- 12-025511-5.50008-6
Liu Q, Sun JD, Wang J, Ahluwalia D, Baker AF, Cranmer LD, Ferraro D, Wang Y, Duan JX, Ammons WS, Curd JG, Matteucci MD, Hart CP. 2012. TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules. Cancer Chemotherapy and Pharmacology 69:1487–1498. DOI: https://doi.org/10.1007/s00280-012-1852-8, PMID: 22382881
Liu Y, Zhang Y, Mao X, Qi Q, Zhu M, Zhang C. 2017a. Palliative treatment efficacy of glucose inhibition combined with chemotherapy for non-small cell lung cancer with widespread bone and brain metastases: a case report. PanBiomed Rep 7:553–557. DOI: https://doi.org/10.3892/br.2017.1008
Liu Q, Stewart J, Wang H, Rashid A, Zhao J, Katz MH, Lee JE, Fleming JB, Maitra A, Wolff RA, Varadhachary GR, Krishnan S, Wang H. 2017b. Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma. PLOS ONE 12:e0171985. DOI: https://doi.org/10. 1371/journal.pone.0171985, PMID: 28187218
Mathews EH, Stander BA, Joubert AM, Liebenberg L. 2014. Tumor cell culture survival following glucose and glutamine deprivation at typical physiological concentrations. Nutrition 30:218–227. DOI: https://doi.org/10. 1016/j.nut.2013.07.024, PMID: 24262514
Matsumoto S, Saito K, Takakusagi Y, Matsuo M, Munasinghe JP, Morris HD, Lizak MJ, Merkle H, Yasukawa K, Devasahayam N, Suburamanian S, Mitchell JB, Krishna MC. 2014. In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization. Antioxidants & Redox Signaling 21:1145–1155. DOI: https://doi.org/ 10.1089/ars.2013.5725, PMID: 24597714
Matsumoto S, Kishimoto S, Saito K, Takakusagi Y, Munasinghe JP, Devasahayam N, Hart CP, Gillies RJ, Mitchell JB, Krishna MC. 2018. Metabolic and physiologic imaging biomarkers of the tumor microenvironment predict treatment outcome with radiation or a Hypoxia-Activated prodrug in mice. Cancer Research 78:3783–3792. DOI: https://doi.org/10.1158/0008-5472.CAN-18-0491, PMID: 29792309
McGranaghan P, Rennefahrt U, Kamlage B, Reszka R, Schatz P, Bethan B, Mayerle J, Lerch MM. 2016. Approaching pancreatic Cancer phenotypes via Metabolomics, in pancreatic Cancer. Pancreatic Cancer:1305– 1324. DOI: https://doi.org/10.1007/978-1-4939-6631-8_61-1
Mirnezami R, Spagou K, Vorkas PA, Lewis MR, Kinross J, Want E, Shion H, Goldin RD, Darzi A, Takats Z, Holmes E, Cloarec O, Nicholson JK. 2014. Chemical mapping of the colorectal Cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects. Molecular Oncology 8: 39–49. DOI: https://doi.org/10.1016/j.molonc.2013.08.010, PMID: 24112879
Pavlova NN, Thompson CB. 2016. The emerging hallmarks of Cancer metabolism. Cell Metabolism 23:27–47. DOI: https://doi.org/10.1016/j.cmet.2015.12.006, PMID: 26771115
Rabinovich S, Adler L, Yizhak K, Sarver A, Silberman A, Agron S, Stettner N, Sun Q, Brandis A, Helbling D, Korman S, Itzkovitz S, Dimmock D, Ulitsky I, Nagamani SC, Ruppin E, Erez A. 2015. Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. Nature 527:379–383. DOI: https://doi.org/10. 1038/nature15529, PMID: 26560030
Rai G, Brimacombe KR, Mott BT, Urban DJ, Hu X, Yang SM, Lee TD, Cheff DM, Kouznetsova J, Benavides GA, Pohida K, Kuenstner EJ, Luci DK, Lukacs CM, Davies DR, Dranow DM, Zhu H, Sulikowski G, Moore WJ, Stott GM, et al. 2017. Discovery and optimization of potent, Cell-Active Pyrazole-Based inhibitors of lactate dehydrogenase (LDH). Journal of Medicinal Chemistry 60:9184–9204. DOI: https://doi.org/10.1021/acs. jmedchem.7b00941, PMID: 29120638
Rodrigues TB, Serrao EM, Kennedy BW, Hu DE, Kettunen MI, Brindle KM. 2014. Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose. Nature Medicine 20:93–97. DOI: https://doi.org/ 10.1038/nm.3416, PMID: 24317119
Saunier E, Benelli C, Bortoli S. 2016. The pyruvate dehydrogenase complex in Cancer: an old metabolic gatekeeper regulated by new pathways and pharmacological agents. International Journal of Cancer 138:809– 817. DOI: https://doi.org/10.1002/ijc.29564, PMID: 25868605
Seaman MA, Levin JR, Serlin RC. 1991. New developments in pairwise multiple comparisons: some powerful and practicable procedures. Psychological Bulletin 110:577–586. DOI: https://doi.org/10.1037/0033-2909.110.3.577
Sherman MH, Yu RT, Tseng TW, Sousa CM, Liu S, Truitt ML, He N, Ding N, Liddle C, Atkins AR, Leblanc M, Collisson EA, Asara JM, Kimmelman AC, Downes M, Evans RM. 2017. Stromal cues regulate the pancreatic Cancer epigenome and metabolome. PNAS 114:1129–1134. DOI: https://doi.org/10.1073/pnas.1620164114, PMID: 28096419
Sonveaux P, Ve´ gran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW. 2008. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. Journal of Clinical Investigation 118:3930–3942. DOI: https://doi. org/10.1172/JCI36843, PMID: 19033663
Sousa CM, Biancur DE, Wang X, Halbrook CJ, Sherman MH, Zhang L, Kremer D, Hwang RF, Witkiewicz AK, Ying H, Asara JM, Evans RM, Cantley LC, Lyssiotis CA, Kimmelman AC. 2016. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature 536:479–483. DOI: https://doi.org/10.1038/ nature19084, PMID: 27509858
Sullivan LB, Martinez-Garcia E, Nguyen H, Mullen AR, Dufour E, Sudarshan S, Licht JD, Deberardinis RJ, Chandel NS. 2013. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Molecular Cell 51:236–248. DOI: https://doi.org/10.1016/j.molcel.2013.05.003, PMID: 23747014
Svensson RU, Parker SJ, Eichner LJ, Kolar MJ, Wallace M, Brun SN, Lombardo PS, Van Nostrand JL, Hutchins A, Vera L, Gerken L, Greenwood J, Bhat S, Harriman G, Westlin WF, Harwood HJ, Saghatelian A, Kapeller R, Metallo CM, Shaw RJ. 2016. Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small-cell lung Cancer in preclinical models. Nature Medicine 22:1108–1119. DOI: https://doi. org/10.1038/nm.4181, PMID: 27643638
Timm KN, Hartl J, Keller MA, Hu DE, Kettunen MI, Rodrigues TB, Ralser M, Brindle KM. 2015. Hyperpolarized [U-(2) H, U-(13) C]Glucose reports on glycolytic and pentose phosphate pathway activity in EL4 tumors and
glycolytic activity in yeast cells. Magnetic Resonance in Medicine 74:1543–1547. DOI: https://doi.org/10.1002/mrm.25561, PMID: 25522215
van Beek JD. 2007. matNMR: a flexible toolbox for processing, analyzing and visualizing magnetic resonance data in matlab. Journal of Magnetic Resonance 187:19–26. DOI: https://doi.org/10.1016/j.jmr.2007.03.017, PMID: 17448713
Vander Heiden MG, DeBerardinis RJ. 2017. Understanding the intersections between metabolism and Cancer biology. Cell 168:657–669. DOI: https://doi.org/10.1016/j.cell.2016.12.039, PMID: 28187287
Wang AS, Lodi A, Rivera LB, Izquierdo-Garcia JL, Firpo MA, Mulvihill SJ, Tempero MA, Bergers G, Ronen SM. 2014. HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic Cancer. NMR in Biomedicine 27:1361–1370. DOI: https://doi.org/10.1002/nbm.3198, PMID: 25199993
Ward PS, Thompson CB. 2012. Metabolic reprogramming: a Cancer hallmark even warburg did not anticipate.
Cancer Cell 21:297–308. DOI: https://doi.org/10.1016/j.ccr.2012.02.014, PMID: 22439925
Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, Fung C, Nikolai L, Lewis M, Coutouly MA, Forsythe I, Tang P, Shrivastava S, Jeroncic K, Stothard P, Amegbey G, et al. 2007. HMDB: the human metabolome database. Nucleic Acids Research 35:D521–D526. DOI: https://doi.org/ 10.1093/nar/gkl923, PMID: 17202168
Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Va´ zquez-Fresno R, Sajed T, Johnson D, Li C, Karu N, Sayeeda Z, Lo E, Assempour N, Berjanskii M, Singhal S, Arndt D, Liang Y, Badran H, Grant J, Serra-Cayuela A, et al. 2018. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Research 46:D608–D617. DOI: https://doi.org/10.1093/nar/gkx1089, PMID: 29140435
Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H, Bause A, Li Y, Stommel JM, Dell’antonio G, Mautner J, Tonon G, Haigis M, Shirihai OS, Doglioni C, Bardeesy N, Kimmelman AC. 2011. Pancreatic cancers require autophagy for tumor growth. Genes & Development 25:717–729. DOI: https://doi.org/10.1101/gad.2016111, PMID: 21406549
Yang M, Soga T, Pollard PJ, Adam J. 2012. The emerging role of fumarate as an oncometabolite. Frontiers in Oncology 2:1–7. DOI: https://doi.org/10.3389/fonc.2012.00085
Ying H, Kimmelman AC, Lyssiotis CA, Hua S, Chu GC, Fletcher-Sananikone E, Locasale JW, Son J, Zhang H, Coloff JL, Yan H, Wang W, Chen S, Viale A, Zheng H, Paik JH, Lim C, Guimaraes AR, Martin ES, Chang J, et al. 2012. Oncogenic kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149:656–670. DOI: https://doi.org/10.1016/j.cell.2012.01.058, PMID: 22541435
Zhang X, Wojtkowiak JW, Martinez GV, Cornnell HH, Hart CP, Baker AF, Gillies R. 2016. MR imaging biomarkers to monitor early response to Hypoxia-Activated prodrug TH-302 in pancreatic Cancer xenografts. PLOS ONE 11:e0155289. DOI: https://doi.org/10.1371/journal.pone.0155289, PMID: 27227903
Zhu G, Bax A. 1992. Improved linear prediction of damped NMR signals using modified “forward-backward” linear prediction. Journal of Magnetic Resonance 100:202–207. DOI: https://doi.org/10.1016/0022-2364(92) 90379-L
Zierhut ML, Yen YF, Chen AP, Bok R, Albers MJ, Zhang V, Tropp J, Park I, Vigneron DB, Kurhanewicz J, Hurd RE, Nelson SJ. 2010. Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice. Journal of Magnetic Resonance 202:85–92. DOI: https://doi.org/10.1016/j.jmr.2009.10.003, PMID: 1 9884027
論文の公開元へ
